schliessen

Filtern

 

Bibliotheken

n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review

Historically, epidemiologic studies have reported a lower prevalence of impaired glucose tolerance and type 2 diabetes in populations consuming large amounts of the n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs) found mainly in fish. Controlled clinical studies have shown that consumption... Full description

Journal Title: Journal of the American Dietetic Association 2005, Vol.105 (3), p.428-440
Main Author: Nettleton, Joyce A
Other Authors: Katz, Robert
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: New York, NY: Elsevier Inc
ID: ISSN: 0002-8223
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_67482724
title: n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review
format: Article
creator:
  • Nettleton, Joyce A
  • Katz, Robert
subjects:
  • Abridged Index Medicus
  • Biological and medical sciences
  • Blood Glucose - metabolism
  • Cardiovascular Diseases - diet therapy
  • Cardiovascular Diseases - prevention & control
  • Diabetes
  • Diabetes Mellitus, Type 2 - complications
  • Diabetes Mellitus, Type 2 - diet therapy
  • Diabetes Mellitus, Type 2 - prevention & control
  • Diabetes. Impaired glucose tolerance
  • Diabetics
  • Endocrine pancreas. Apud cells (diseases)
  • Endocrinopathies
  • Epidemiology
  • Fatty acids
  • Fatty Acids, Omega-3 - administration & dosage
  • Fatty Acids, Omega-3 - therapeutic use
  • Food and nutrition
  • Glucose
  • Health risk assessment
  • Humans
  • Insulin - metabolism
  • Insulin Resistance
  • Management. Various non-drug treatments. Langerhans islet grafts
  • Medical sciences
  • Metabolic Syndrome - complications
  • Metabolic Syndrome - diet therapy
  • Metabolic Syndrome - prevention & control
  • Nutritional aspects
  • Obesity - complications
  • Obesity - diet therapy
  • Obesity - prevention & control
  • Risk Factors
  • Type 2 diabetes
  • Unsaturated fatty acids
ispartof: Journal of the American Dietetic Association, 2005, Vol.105 (3), p.428-440
description: Historically, epidemiologic studies have reported a lower prevalence of impaired glucose tolerance and type 2 diabetes in populations consuming large amounts of the n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs) found mainly in fish. Controlled clinical studies have shown that consumption of n-3 LC-PUFAs has cardioprotective effects in persons with type 2 diabetes without adverse effects on glucose control and insulin activity. Benefits include lower risk of primary cardiac arrest; reduced cardiovascular mortality, particularly sudden cardiac death; reduced triglyceride levels; increased high-density lipoprotein levels; improved endothelial function; reduced platelet aggregability; and lower blood pressure. These favorable effects outweigh the modest increase in low-density lipoprotein levels that may result from increased n-3 LC-PUFA intake. Preliminary evidence suggests increased consumption of n-3 LC-PUFAs with reduced intake of saturated fat may reduce the risk of conversion from impaired glucose tolerance to type 2 diabetes in overweight persons. Reported improvements in hemostasis, slower progression of artery narrowing, albuminuria, subclinical inflammation, oxidative stress, and obesity require additional confirmation. Expected health benefits and public health implications of consuming 1 to 2 g/day n-3 LC-PUFA as part of lifestyle modification in insulin resistance and type 2 diabetes are discussed.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0002-8223
fulltext: fulltext
issn:
  • 0002-8223
  • 1878-3570
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK1.9302994
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_67482724
sourceformatXML
sourcesystemPC
galeidA131018834
sourcerecordidA131018834
originalsourceidFETCH-LOGICAL-1559t-acfa0f6c961621bab4642a83627a2df9352d7a70c3ca7adc04f1be215340f9b63
addsrcrecordideNp9kl2L1DAUhoso7rj6B7yQoih40ZqPNk3Fm2HRURjwRq_DaXIypnTaMUlX59-bMgPLLLLkIiR53vP1JsteUlJSQsWHvuzBQMkIqUpKS8LaR9mKykYWvG7I42xFCGGFZIxfZc9C6NOR1JQ8za5o3VRCcrbKNmPB82Ead4X-BW7MD9NwnMcAcfYQ0eQWYjzmoJ0JeXqOxwPmLDcOOowYPubr3OOtwz_PsycWhoAvzvt19vPL5x83X4vt9823m_W2oHXdxgK0BWKFbgUVjHbQVaJiILlgDTBjW14z00BDNNfQgNGksrRDRmteEdt2gl9n705xD376PWOIau-CxmGAEac5KNFUkjWsSuDre2A_zX5MtSlGZUVF28oEvTlBOxhQudFO0YNeIqo15WnIUvIlVPkfKi2De6enEa1L9xeC9xeCxET8G3cwh6DkZnvJshOr_RSCR6sO3u3BHxUlarFZ9WqxWS02K0pVsjmJXp2bm7s9mjvJ2dcEvD0DEDQM1sOoXbjjRN2m_pdxynvZtYsQXSrYgxseruHTSYrJ7vQFvAra4ajROI86KjO5h-T_AHO203E
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid218416998
display
typearticle
titlen-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review
sourceAlma/SFX Local Collection
creatorNettleton, Joyce A ; Katz, Robert
creatorcontribNettleton, Joyce A ; Katz, Robert
descriptionHistorically, epidemiologic studies have reported a lower prevalence of impaired glucose tolerance and type 2 diabetes in populations consuming large amounts of the n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs) found mainly in fish. Controlled clinical studies have shown that consumption of n-3 LC-PUFAs has cardioprotective effects in persons with type 2 diabetes without adverse effects on glucose control and insulin activity. Benefits include lower risk of primary cardiac arrest; reduced cardiovascular mortality, particularly sudden cardiac death; reduced triglyceride levels; increased high-density lipoprotein levels; improved endothelial function; reduced platelet aggregability; and lower blood pressure. These favorable effects outweigh the modest increase in low-density lipoprotein levels that may result from increased n-3 LC-PUFA intake. Preliminary evidence suggests increased consumption of n-3 LC-PUFAs with reduced intake of saturated fat may reduce the risk of conversion from impaired glucose tolerance to type 2 diabetes in overweight persons. Reported improvements in hemostasis, slower progression of artery narrowing, albuminuria, subclinical inflammation, oxidative stress, and obesity require additional confirmation. Expected health benefits and public health implications of consuming 1 to 2 g/day n-3 LC-PUFA as part of lifestyle modification in insulin resistance and type 2 diabetes are discussed.
identifier
0ISSN: 0002-8223
1EISSN: 1878-3570
2DOI: 10.1016/j.jada.2004.11.029
3PMID: 15746832
4CODEN: JADAAE
languageeng
publisherNew York, NY: Elsevier Inc
subjectAbridged Index Medicus ; Biological and medical sciences ; Blood Glucose - metabolism ; Cardiovascular Diseases - diet therapy ; Cardiovascular Diseases - prevention & control ; Diabetes ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - diet therapy ; Diabetes Mellitus, Type 2 - prevention & control ; Diabetes. Impaired glucose tolerance ; Diabetics ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Epidemiology ; Fatty acids ; Fatty Acids, Omega-3 - administration & dosage ; Fatty Acids, Omega-3 - therapeutic use ; Food and nutrition ; Glucose ; Health risk assessment ; Humans ; Insulin - metabolism ; Insulin Resistance ; Management. Various non-drug treatments. Langerhans islet grafts ; Medical sciences ; Metabolic Syndrome - complications ; Metabolic Syndrome - diet therapy ; Metabolic Syndrome - prevention & control ; Nutritional aspects ; Obesity - complications ; Obesity - diet therapy ; Obesity - prevention & control ; Risk Factors ; Type 2 diabetes ; Unsaturated fatty acids
ispartofJournal of the American Dietetic Association, 2005, Vol.105 (3), p.428-440
rights
02005 American Dietetic Association
12005 INIST-CNRS
2Copyright American Dietetic Association Mar 2005
citedbyFETCH-LOGICAL-1559t-acfa0f6c961621bab4642a83627a2df9352d7a70c3ca7adc04f1be215340f9b63
citesFETCH-LOGICAL-1559t-acfa0f6c961621bab4642a83627a2df9352d7a70c3ca7adc04f1be215340f9b63
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16599986$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15746832$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Nettleton, Joyce A
1Katz, Robert
title
0n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review
1Journal of the American Dietetic Association
addtitleJ Am Diet Assoc
descriptionHistorically, epidemiologic studies have reported a lower prevalence of impaired glucose tolerance and type 2 diabetes in populations consuming large amounts of the n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs) found mainly in fish. Controlled clinical studies have shown that consumption of n-3 LC-PUFAs has cardioprotective effects in persons with type 2 diabetes without adverse effects on glucose control and insulin activity. Benefits include lower risk of primary cardiac arrest; reduced cardiovascular mortality, particularly sudden cardiac death; reduced triglyceride levels; increased high-density lipoprotein levels; improved endothelial function; reduced platelet aggregability; and lower blood pressure. These favorable effects outweigh the modest increase in low-density lipoprotein levels that may result from increased n-3 LC-PUFA intake. Preliminary evidence suggests increased consumption of n-3 LC-PUFAs with reduced intake of saturated fat may reduce the risk of conversion from impaired glucose tolerance to type 2 diabetes in overweight persons. Reported improvements in hemostasis, slower progression of artery narrowing, albuminuria, subclinical inflammation, oxidative stress, and obesity require additional confirmation. Expected health benefits and public health implications of consuming 1 to 2 g/day n-3 LC-PUFA as part of lifestyle modification in insulin resistance and type 2 diabetes are discussed.
subject
0Abridged Index Medicus
1Biological and medical sciences
2Blood Glucose - metabolism
3Cardiovascular Diseases - diet therapy
4Cardiovascular Diseases - prevention & control
5Diabetes
6Diabetes Mellitus, Type 2 - complications
7Diabetes Mellitus, Type 2 - diet therapy
8Diabetes Mellitus, Type 2 - prevention & control
9Diabetes. Impaired glucose tolerance
10Diabetics
11Endocrine pancreas. Apud cells (diseases)
12Endocrinopathies
13Epidemiology
14Fatty acids
15Fatty Acids, Omega-3 - administration & dosage
16Fatty Acids, Omega-3 - therapeutic use
17Food and nutrition
18Glucose
19Health risk assessment
20Humans
21Insulin - metabolism
22Insulin Resistance
23Management. Various non-drug treatments. Langerhans islet grafts
24Medical sciences
25Metabolic Syndrome - complications
26Metabolic Syndrome - diet therapy
27Metabolic Syndrome - prevention & control
28Nutritional aspects
29Obesity - complications
30Obesity - diet therapy
31Obesity - prevention & control
32Risk Factors
33Type 2 diabetes
34Unsaturated fatty acids
issn
00002-8223
11878-3570
fulltexttrue
rsrctypearticle
creationdate2005
recordtypearticle
recordideNp9kl2L1DAUhoso7rj6B7yQoih40ZqPNk3Fm2HRURjwRq_DaXIypnTaMUlX59-bMgPLLLLkIiR53vP1JsteUlJSQsWHvuzBQMkIqUpKS8LaR9mKykYWvG7I42xFCGGFZIxfZc9C6NOR1JQ8za5o3VRCcrbKNmPB82Ead4X-BW7MD9NwnMcAcfYQ0eQWYjzmoJ0JeXqOxwPmLDcOOowYPubr3OOtwz_PsycWhoAvzvt19vPL5x83X4vt9823m_W2oHXdxgK0BWKFbgUVjHbQVaJiILlgDTBjW14z00BDNNfQgNGksrRDRmteEdt2gl9n705xD376PWOIau-CxmGAEac5KNFUkjWsSuDre2A_zX5MtSlGZUVF28oEvTlBOxhQudFO0YNeIqo15WnIUvIlVPkfKi2De6enEa1L9xeC9xeCxET8G3cwh6DkZnvJshOr_RSCR6sO3u3BHxUlarFZ9WqxWS02K0pVsjmJXp2bm7s9mjvJ2dcEvD0DEDQM1sOoXbjjRN2m_pdxynvZtYsQXSrYgxseruHTSYrJ7vQFvAra4ajROI86KjO5h-T_AHO203E
startdate2005
enddate2005
creator
0Nettleton, Joyce A
1Katz, Robert
general
0Elsevier Inc
1Elsevier
2Elsevier Science Publishers
3Elsevier Limited
scope
0IQODW
1CGR
2CUY
3CVF
4ECM
5EIF
6NPM
7AAYXX
8CITATION
9BSHEE
107QP
117TS
12K9.
137X8
sort
creationdate2005
titlen-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review
authorNettleton, Joyce A ; Katz, Robert
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1559t-acfa0f6c961621bab4642a83627a2df9352d7a70c3ca7adc04f1be215340f9b63
rsrctypearticles
prefilterarticles
languageeng
creationdate2005
topic
0Abridged Index Medicus
1Biological and medical sciences
2Blood Glucose - metabolism
3Cardiovascular Diseases - diet therapy
4Cardiovascular Diseases - prevention & control
5Diabetes
6Diabetes Mellitus, Type 2 - complications
7Diabetes Mellitus, Type 2 - diet therapy
8Diabetes Mellitus, Type 2 - prevention & control
9Diabetes. Impaired glucose tolerance
10Diabetics
11Endocrine pancreas. Apud cells (diseases)
12Endocrinopathies
13Epidemiology
14Fatty acids
15Fatty Acids, Omega-3 - administration & dosage
16Fatty Acids, Omega-3 - therapeutic use
17Food and nutrition
18Glucose
19Health risk assessment
20Humans
21Insulin - metabolism
22Insulin Resistance
23Management. Various non-drug treatments. Langerhans islet grafts
24Medical sciences
25Metabolic Syndrome - complications
26Metabolic Syndrome - diet therapy
27Metabolic Syndrome - prevention & control
28Nutritional aspects
29Obesity - complications
30Obesity - diet therapy
31Obesity - prevention & control
32Risk Factors
33Type 2 diabetes
34Unsaturated fatty acids
toplevelonline_resources
creatorcontrib
0Nettleton, Joyce A
1Katz, Robert
collection
0Pascal-Francis
1Medline
2MEDLINE
3MEDLINE (Ovid)
4MEDLINE
5MEDLINE
6PubMed
7CrossRef
8Academic OneFile (A&I only)
9Calcium & Calcified Tissue Abstracts
10Physical Education Index
11ProQuest Health & Medical Complete (Alumni)
12MEDLINE - Academic
jtitleJournal of the American Dietetic Association
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Nettleton, Joyce A
1Katz, Robert
formatjournal
genrearticle
ristypeJOUR
atitlen-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review
jtitleJournal of the American Dietetic Association
addtitleJ Am Diet Assoc
date2005
risdate2005
volume105
issue3
spage428
epage440
pages428-440
issn0002-8223
eissn1878-3570
codenJADAAE
abstractHistorically, epidemiologic studies have reported a lower prevalence of impaired glucose tolerance and type 2 diabetes in populations consuming large amounts of the n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs) found mainly in fish. Controlled clinical studies have shown that consumption of n-3 LC-PUFAs has cardioprotective effects in persons with type 2 diabetes without adverse effects on glucose control and insulin activity. Benefits include lower risk of primary cardiac arrest; reduced cardiovascular mortality, particularly sudden cardiac death; reduced triglyceride levels; increased high-density lipoprotein levels; improved endothelial function; reduced platelet aggregability; and lower blood pressure. These favorable effects outweigh the modest increase in low-density lipoprotein levels that may result from increased n-3 LC-PUFA intake. Preliminary evidence suggests increased consumption of n-3 LC-PUFAs with reduced intake of saturated fat may reduce the risk of conversion from impaired glucose tolerance to type 2 diabetes in overweight persons. Reported improvements in hemostasis, slower progression of artery narrowing, albuminuria, subclinical inflammation, oxidative stress, and obesity require additional confirmation. Expected health benefits and public health implications of consuming 1 to 2 g/day n-3 LC-PUFA as part of lifestyle modification in insulin resistance and type 2 diabetes are discussed.
copNew York, NY
pubElsevier Inc
pmid15746832
doi10.1016/j.jada.2004.11.029
tpages13